Cleary Kevin Michael
CIK: 0001952022
Cleary Kevin Michael's purchase track record
Cleary Kevin Michael has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/5/2022 | GROV | $59K | -12.5% | -25.0% | +6.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| GROV | ▲ Buy | Option Exercise | 32,222 | — | 5/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 21,241 | — | 5/15/2024 | View on chart |
| GROV | ▲ Buy | Option Exercise | 106,209 | — | 5/15/2023 | View on chart |
| GROV | ▲ Buy | Open Market | 100,000 | $59K | 12/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Grove Collaborative adds SenesTech rodent control to its e‑commerce catalog
Grove Collaborative announced that it will distribute SenesTech’s Evolve® rodent birth control products through its third‑party e‑commerce channels. The partnership targets consumers who prioritize sustainable household solutions. The addition broadens Grove’s product lineup and may attract new shoppers to its platform. The stock is currently near its $1.03 support level, which has been tested repeatedly.
Grove Collaborative adds SenesTech rodent control to its e‑commerce catalog. Grove Collaborative announced that it will distribute SenesTech’s Evolve® rodent birth control products through its third‑party e‑commerce channels. The partnership targets consumers who prioritize sustainable household solutions. The addition broadens Grove’s product lineup and may attract new shoppers to its platform. The stock is currently near its $1.03 support level, which has been tested repeatedly.